Small-vessel vasculitis

New England Journal of Medicine

Volumn 337, Issue 21, 1997, Pages 1512-1523

  Jennette, J Charles ^a   Falk, Ronald J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANAPHYLACTOID PURPURA; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOLOGY; HUMAN; NECROTIZING ARTERITIS; PRIORITY JOURNAL; REVIEW; VASCULITIS; WEGENER GRANULOMATOSIS;

DIAGNOSIS, DIFFERENTIAL; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MICROCIRCULATION; VASCULITIS;

EID: 0030725347     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199711203372106     Document Type: Review

References (99)

1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Kussmaul A, Maier R. Ueber eine bisher nicht beschreibene eigenthümliche Arterienerkrankung (Periarteriitis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med 1866;1:484-518.
3. Arkin A. A clinical and pathological study of periarteritis nodosa: a report of five cases, one histologically healed. Am J Pathol 1930;6:401-26.
4. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. QJM 1948; 17:175-202.
5. Zeek PM, Smith CC, Weeter JC. Studies on periarteritis nodosa. III. The differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity. Am J Pathol 1948;24:889-917.
6. Zeek PM. Periarteritis nodosa: a critical review. Am J Clin Pathol 1952; 22:777-90.
7. Godman GC, Churg J. Wegener's granulomatosis: pathology and review of the literature. Arch Pathol 1954;58:533-53.
8. Klinger H. Grenzformen der Periarteriitis nodosa. Frankf Z Pathol 1931;42:455-80.
9. Wegener F. Über eine eigenartige rhinogene Granulomatose mit besonderer Beteilgung des Arteriensystems und den Nieren. Beirr Pathol Anat Allg Pathol 1939;102:36-68.
10. Carrington CB, Liebow AA. Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 1966;41:497-527.
11. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27:277-94.
12. Alarcón-Segovia D. Classification of the necrotizing vasculitides in man. Clin Rheum Dis 1980;6:223-31.
13. Purpura. In: Willan R. On cutaneous diseases. Vol. 1. Philadelphia: Kimber & Conrad, 1808:452-71.
14. Schönlein JL. Allgemeine und specielle Pathologie und Therapie. 3rd ed. Vol. 2. Herisau, Switzerland: Literatur-Comptoir, 1837:48.
15. Henoch E. Über den Zusammenhang von Purpura und Intestinal störungen. Berl Klin Wochenschr 1868;5:517-9.
16. Henoch EH. Lectures on diseases of children: a handbook for physicians and students. New York: W. Wood, 1882.
17. Osler W. On the visceral complications of erythema exudativum multiforme. Am J Med Sci 1895;110:629-46.
18. Idem. The visceral lesions of purpura and allied conditions. BMJ 1914; 1:517-25.
19. Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 1919;158:863-70.
20. Martinez JS, Kohler PF. Variant "Goodpasture's syndrome"? The need for immunologic criteria in rapidly progressive glomerulonephritis and hemorrhagic pneumonitis. Ann Intern Med 1971;75:67-76.
21. Leatherman JW, Sibley RK, Davies SF. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to anti-glomerular basement membrane antibody. Am J Med 1982;72:401-10.
22. Niles JL, Bottinger EP, Saurina GR, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996;156:440-5.
23. Jones DA, Jennette JC, Falk RJ. Goodpasture's syndrome revisited: a new perspective on glomerulonephritis and alveolar hemorrhage. N C Med J 1990;51:411-5.
24. Storck H. Über hämorrhagische Phänomene in der Dermatologie. Dermatologica 1951;102:197-252.
25. Winklemann RK. Clinical and pathologic findings in the skin in anaphylactoid purpura (allergic angiitis). Mayo Clin Proc 1958;33:277-88.
26. Clark E, Kaplan BI. Endocardial, arterial and other mesenchymal alterations associated with serum disease in man. Arch Pathol 1937;24:458-75.
27. Winkelmann RK, Ditto WB. Cutaneous and visceral syndromes of necrotizing or "allergic" angiitis: a study of 38 cases. Medicine (Baltimore) 1964;43:59-89.
28. Alarcón-Segovia D, Brown AL Jr. Classification and etiologic aspects of necrotizing angiitides: an analytic approach to a confused subject with a critical review of the evidence for hypersensitivity in polyarteritis nodosa. Mayo Clin Proc 1964;39:205-22.
29. Scheer RL, Grossman MA. Immune aspects of the glomerulonephritis associated with pulmonary hemorrhage. Ann Intern Med 1964;60:1009-21.
30. Sturgill BC, Westervelt FB. Immunofluorescence studies in a case of Goodpasture's syndrome. JAMA 1965;194:914-6.
31. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967;126:989-1004.
32. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia - a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966;40:837-56.
33. Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood vessel walls and mesangium in Henoch-Schönlein syndrome. Lancet 1973;1:892-3.
34. Gower RG, Sausker WF, Kohler PF, Thorne GE, McIntosh RM. Small vessel vasculitis caused by hepatitis B virus immune complexes: small vessel vasculitis and HBsAG. J Allergy Clin Immunol 1978;62:222-8.
35. Ronco P, Verroust P, Mignon F, et al. Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies. QJM 1983;52:212-23.
36. Weiss MA, Crissman JD. Renal biopsy findings in Wegener's granulomatosis: segmental necrotizing glomerulonephritis with glomerular thrombosis. Hum Pathol 1984;15:943-56.
37. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? BMJ 1982;285:606.
38. Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N Z J Med 1984;14:277-8.
39. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-9.
40. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91: 1-12.
41. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiologic potential. Kidney Int 1994;46:1-15.
42. Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic autoantibodies: discovery, specificity, disease associations and pathogenic potential. Adv Pathol Lab Med 1995;8:363-78.
43. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
44. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84:1577-87.
45. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74:1888-93.
46. Ludemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-62.
47. Jennette JC, Hoidal JR, Falk RJ. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 1990;75:2263-4.
48. Merkel PA, Polisson RP, Chang YC, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997;126:866-73.
49. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990;33:1114-21.
50. Michel BA, Hunder GG, Bloch DA, Calabrese LH. Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the 2 disorders. J Rheumatol 1992;19:721-8.
51. Goldstein AR, White RHR, Akuse R, Chantler C. Long-term followup of childhood Henoch-Schönlein nephritis. Lancet 1992;339:280-2.
52. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long term follow-up of 40 patients. Am J Med 1980;69:287-308.
53. Agnello V, Romain PL. Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am 1996;22:1-21.
54. Pettersson EE, Sundelin B, Heigl Z. Incidence and outcome of pauci-immune nccrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 1995;43:141-9.
55. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
56. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
57. Duna GF, Galperin C, Hoffman GS. Wegener's granulomatosis. Rheum Dis Clin North Am 1995;21:949-86.
58. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:33-9.
59. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
60. Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol 1996;35:958-64.
61. Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. QJM 1985; 220:467-83.
62. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects and treatment. Rheum Dis Clin North Am 1995;21:911-47.
63. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ, Glomerular Disease Collaborative Network. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.
64. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg Strauss syndrome. Medicine (Baltimore) 1984;63:65-81.
65. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
66. Jennette JC, Milling DM, Falk RJ. Vasculitis affecting the skin: a review. Arch Dermatol 1994;130:899-906.
67. Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26:441-8.
68. Panegyres PK, Blumbergs PC, Leong AS, Bourne AJ. Vasculitis of peripheral nerve and skeletal muscle: clinicopathological correlation and immunopathic mechanisms. J Neurol Sci 1990;100:193-202.
69. Kissel JT, Mendell JR. Vasculitic neuropathy. Neurol Clin 1992;10: 761-81.
70. Gaudin PB, Askin FB, Falk RJ, Jennette JC. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995;104:7-16.
71. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum 1990;33:1065-7.
72. Ekenstam E, Callen JP. Cutaneous leukocytoclastic vasculitis: clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol 1984;120:484-9.
73. Sanchez NP, Van Hale HM, Su WPD. Clinical and histopathologic spectrum of necrotizing vasculitis: report of findings in 101 cases. Arch Dermatol 1985;121:220-4.
74. Wolkenstein P, Revuz J. Drug-induced severe skin reactions: incidence, management and prevention. Drug Saf 1995;13:56-68.
75. Parker CW. Drug allergy. N Engl J Med 1975;292:511-4.
76. Lantin JP, Gattesco S, Duclos A, et al. Anaphylactoid purpura like vasculitis following fibrinolytic therapy: role of the immune response to streptokinase. Clin Exp Rheumatol 1994;12:429-33.
77. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase antineutrophil cytoplasmic antibody-positive crescentic glomcrulonephritis complicating the course of Graves' disease: report of three adult cases. Am J Kidney Dis 1995;26:774-80.
78. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993;342:651-2.
79. Short AK, Lockwood CM. Antigen specificity of hydralazine associated ANCA positive systemic vasculitis. QJM 1995;88:775-83.
80. D'Cruz D, Chesser AM, Lightowler C, et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with antithyroid drug treatment. Br J Rheumatol 1995;34:1090-1.
81. Swerlick RA, Lawley TJ. Cutaneous vasculitis: its relationship to systemic disease. Med Clin North Am 1989;73:1221-35.
82. Dillon MJ, Ansell BM. Vasculitis in children and adolescents. Rheum Dis Clin North Am 1995;21:1115-36.
83. Wright WK, Krous HF, Griswold WR, et al. Pulmonary vasculitis with hemorrhage in anaphylactoid purpura. Pediatr Pulmonol 1994;17:269-71.
84. Belman AL, Leicher CR, Moshe SL, Mezey AP. Neurologic manifestations of Schoenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 1985;75:687-92.
85. Bergstein J, Leiser J, Andreoli S. Response of crescentic Henoch-Schoenlein purpura nephritis (HSP GN) to corticosteroid and azathioprine (AZA) therapy. J Am Soc Nephrol 1996;7:1328-9. abstract.
86. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
87. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995;25:361-9.
88. Jennette JC. Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective. Am J Kidney Dis 1991;18:164-70.
89. Falk RJ, Hogan S, Carey TS, Jennette JC. The clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-63.
90. Savage COS, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8.
91. Gaughan RK, DeSanto LW, McDonald TJ. Use of anticytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis with subglottic stenosis. Laryngoscope 1990;100:561-3.
92. Yamashita K, Kobayashi K, Kondo M, Ishikura H, Shibuya Y, Hayasaka S. Elevated anti-neutrophil cytoplasmic antibody titer in a patient with atypical orbital pseudotumor. Ophthalmologica 1995;209:172-5.
93. Bacon PA. Therapy of vasculitis. J Rheumatol 1994;21:788-90.
94. Novack SN, Pearson CM. Cyclophosphamide therapy in Wegener's granulomatosis. N Engl J Med 1971;284:938-42.
95. Talar-Williams C, Hijazi YM, Walther MM, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996;124:477-84.
96. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995;38:608-13.
97. de Groot K, Reinhold-Keller E, Tatsis E, et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996;39:2052-61.
98. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7.
99. Stegeman CA, Tervaert JWC, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20.